Vision of Progress / $200 Million by 2020

Home About the Pancreatic Cancer Action Network Vision of Progress / $200 Million by 2020

OUR VISION: DOUBLE PANCREATIC CANCER SURVIVAL BY 2020


Of the major cancers, pancreatic cancer has the lowest survival rate.

In 2011, our organization declared a bold and aggressive vision: After seeing too little progress in pancreatic cancer survival in over half a century, the Pancreatic Cancer Action Network put a stake in the ground to double pancreatic cancer survival by 2020.

This is our Vision of Progress.

 

Today we are aiming to raise $200 million by 2020, which will ensure that we continue to accelerate progress.

 

$200 MILLION on the ROAD TO 2020

research fundingAn infusion of funds will allow us to significantly increase our investment in research, fueling our efforts to develop early detection tools and better treatments options for patients.


government affairs and advocacyIt will also support year-round government advocacy efforts on Capitol Hill and ensure federal funding for pancreatic cancer research is a national priority.


patient servicesIncreased funding for patient services will help improve the lives of people battling pancreatic cancer today, as well as those who are diagnosed in the future. More patients will know their options, and possibly have the opportunity to enroll in clinical trials that best match their needs.


icon-kyt-50x50.pngAdditional funding means we can expand the reach of Know Your TumorSM, our personalized medicine service, which provides eligible pancreatic cancer patients and their oncologists with information about the biology of their tumor. Further, information that is gathered through this service can help shape future clinical trials that drive progress for patients.


community outreachAs a result of all of this activity, even greater attention will be focused on the disease across the country and around the world, and more people will have the opportunity to Wage Hope and help rewrite the future of pancreatic cancer.

 

pie-chart-200-million-goal

OUR AGGRESSIVE STRATEGY ADDRESSES 5 key needs

We have identified five key challenges on the road to 2020, but we have a carefully considered plan of attack. Raising $200 million by 2020 will help ensure that we meet these challenges head on.

researcher-resourcesMore researchers and resources

clinical-trialsClinical trials that match patient needs

clinical-trial-enrollmentHigher clinical trial enrollment rate

doctors-best-practicesDoctors delivering best practices

ribbon-awareness-visibilityMore public awareness and visibility


OUR LEADERSHIP IS ACCELERATING PROGRESS:

  • ~100% increase in median overall survival from Phase III clinical trials since 1999
  • ~600% increase in National Cancer Institute funding since 1999
  • ~600% increase in the number of NCI-funded investigators studying pancreatic cancer
  • ~400% increase in the number of annual peer-reviewed pancreatic cancer publications
  • ~600% increase in Patient Central contacts since the program started
  • ~300% increase in PurpleStride participants since 2009

 

YOU DRIVE PROGRESS TOWARD OUR GOAL!

We can’t achieve our goals without you! Wage Hope today in the fight against pancreatic cancer.

A very special thank you to those who have so generously supported our $200 million goal.

Heartfelt gratitude for transformational gifts honoring the memory of Skip Viragh.
Read about Skip here.

Wage Hope With Us

Join us to double pancreatic cancer survival by 2020.






Gear, apparel, accessories and more to show off your purple pride.


Shop Now 

©2018 Pancreatic Cancer Action Network. All rights reserved. Terms of Use | Privacy Policy


Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.


The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.